Results 131 to 140 of about 6,593,466 (305)
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk +10 more
wiley +1 more source
Patient Safety Compass - Volume 10, Issue 11
https://scholarlycommons.baptisthealth.net/bg-bh-patient-safety-compass/1016/thumbnail ...
Baptist Health South Florida, Patient Safety
core
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Patient Safety Compass - Volume 10, Issue 6
https://scholarlycommons.baptisthealth.net/bg-bh-patient-safety-compass/1011/thumbnail ...
Baptist Health South Florida, Patient Safety
core
Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane +19 more
wiley +1 more source
Patient Safety Compass - Volume 10, Issue 9
https://scholarlycommons.baptisthealth.net/bg-bh-patient-safety-compass/1014/thumbnail ...
Baptist Health South Florida, Patient Safety
core
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
... pharmacy annual summary [PDF]
This archived document is maintained by the Oregon State Library as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Began and ceased with 2012Includes bibliographical ...
core
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Patient Safety Compass - Volume 10, Issue 5
https://scholarlycommons.baptisthealth.net/bg-bh-patient-safety-compass/1010/thumbnail ...
Baptist Health South Florida, Patient Safety
core

